Business
Smartlens, Inc. Secures $5.2 Million Bridge Round to Advance FDA Clearance Process and Prepare for Commercial Launch of miLens
Smartlens, Inc., a clinical-stage ophthalmic technology company advancing next-generation glaucoma management devices, today announced the closing of an oversubscribed$5.2 million bridge round led by Ambit Health Ventures. The financing will be used to advance the FDA clearance process and prepare for an expedited market launch following clearance.
About this update from Lens Technology Co. Ltd. Class A
[{"type":"text","content":"Round Led by Ambit Health Ventures Positions Smartlens for Market Entry and Future Growth","length":89,"tagName":"p"},{"type":"text","content":"SUNNYVALE, Calif., Oct. 14, 2025 /PRNewswire/ -- Smartlens, Inc., a clinical-stage ophthalmic technology company advancing next-generation glaucoma management devices, today announced the closing of an oversubscribed$5.2 million bridge round led by Ambit Health Ventures. The financing will be used to advance the FDA clearance process and prepare for an expedited market launch following clearance.","length":404,"tagName":"p"},{"type":"image","alt":"miLens is a groundbreaking electronics-free soft contact lens designed to continuously monitor intraocular pressure (PRNewsfoto/Smartlens, Inc.)","displaySize":"","headline":null,"caption":"miLens is a groundbreaking electronics-free soft contact lens designed to continuously monitor intraocular pressure (PRNewsfoto/Smartlens, Inc.)","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":267,"url":"https://media.zenfs.com/en/prnewswire.com/ebee9714d8c0bad6f310e597e57103a2"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/F3YKplzQBM7rmm8XLrj9Uw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTQ3MTtjZj13ZWJw/https://media.zenfs.com/en/prnewswire.com/ebee9714d8c0bad6f310e597e57103a2","width":400,"height":267}},"href":"https://mma.prnewswire.com/media/2795123/Smartlens_Inc_miLens_is_a_groundbreaking_electronics_free_soft_contact_lens.html","hrefExternal":true,"rel":"nofollow"},{"type":"text","content":"The round also included continued participation from existing investors Graphene Ventures and Boutique Venture Partners, along with new investment from Harvard Business School Alumni Angels GNY and a group of leading eye care providers.","length":241,"tagName":"p"},{"type":"text","content":" miLens is distinguished as the world's first electronics-free contact lens technology capable of continuous intraocular pressure (IOP) monitoring. Working seamlessly with Smartlens' AI-powered smartphone imaging platform, miLens captures critical pressure fluctuations and enables data-driven treatment optimization. The company plans to initiate commercial activities following FDA clearance, marking a major milestone in transforming glaucoma care worldwide.","length":484,"tagName":"p"},{"type":"text","content":"...